Type IIType II DiabetesSleep ProblemsDiabetes & EndocrinologyFamily PracticeNursingPulmonologyInternal MedicineGeriatricsDiabetesType 2 DiabetesSleep Disorder
HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our Editorial and Fact-Checking Policy for more detail.Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
WEDNESDAY, Sept. 30, 2015 (HealthDay News) -- Nocturnal hypoglycemia is associated with reduced awakening response, according to a study published online Sept. 25 in Diabetes Care.
Poul Jennum, M.D., from Copenhagen University Hospital in Denmark, and colleagues conducted a trial involving 26 subjects with type 2 diabetes. Participants attended two experimental night visits (one normoglycemic and one hypoglycemic) in randomized order. On the hypoglycemic night, after participants reached sleep stage N2, glucose infusion was turned off to induce hypoglycemia until the plasma glucose (PG) target of 2.7 to 2.8 mmol/L was reached and maintained for 15 minutes. Subjects were then brought back to normoglycemia, which was maintained for the rest of the night. PG was maintained at 5.0 to 7.0 mmol/L throughout the normoglycemic night.
The researchers observed no difference between the experimental nights in the rate of electroencephalography-identified arousals or awakenings during the first four hours of sleep. Compared with the normoglycemic night, on the hypoglycemic night the rate of awakenings was 27 percent lower during hours four to eight and 20 percent lower during hours zero to eight (both statistically significant). There was a tendency toward longer total sleep time on the hypoglycemic night (observed means, 366 versus 349 minutes; P nonsignificant).
"These findings underscore the risks associated with nocturnal hypoglycemia because nocturnal hypoglycemia potentially affects the patient's ability to wake up and respond with an adequate intake of carbohydrates," the authors write.
Several authors disclosed financial ties to pharmaceutical companies, including Novo Nordisk, which funded the study.
This story may be outdated. We suggest some alternatives.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.
Updated on May 31, 2022
Read this Next
Other Trending Articles